This release focused on how the results of a test changed doctors’ treatment recommendations. It didn’t address whether those revised recommendations would improve outcomes for patients.
This reasonably strong coverage of a new pancreatic cancer test needed a more aggressive rebuttal of claims to “perfect accuracy.”
This story about a new pancreatic cancer test didn’t dig deeper than a news release announcing the study results.
Because pancreatic cancer is, as the story says, highly lethal once diagnosed, a possible early detection test is worth news coverage. But because of those same high stakes, any screening test deserves a thorough critical appraisal.
Tips for Understanding Studies